The Times – Trial to infect British volunteers with modified coronavirus at hVIVO Quarantine Centre September 29, 2020 – Posted in: Open Orphan (ORPH)

Scientists are planning to infect British volunteers with a weakened, computer-designed form of the coronavirus, which researchers believe could work as a vaccine. The early-stage trial will take place in a special 24-bed quarantine clinic in Whitechapel, east London. The US biotech company behind it, Codagenix, is in talks with UK regulators and expects to begin before the end of the year. The vaccine consists of an enfeebled version of the coronavirus, designed using special…

Continue reading

Coronavirus vaccine: wanted — human guinea pigs to be infected with Covid-19 June 8, 2020 – Posted in: Open Orphan (ORPH)

Sabah Meddings Sunday June 07 2020, 12.01am, The Sunday Times Vaccine developers may have to resort to a method known as a ‘human challenge study’ KOEN VAN WEEL Scientists are applying for permission to infect healthy volunteers with Covid-19 amid fears the number of cases in the UK has fallen so steeply that it will be difficult to test potential vaccines. The health research company Hvivo, which runs a quarantine laboratory in east London, has…

Continue reading

Open Orphan #ORPH: The Times – Inside Story of coronavirus battlers. The Sun – We salute the unsung key workers. – Posted in: Open Orphan (ORPH)

Inside stories of coronavirus battlers Aerogen, Hibergene, Open Orphan and Nearform Ireland was placed sixth last week in a list of nations ranked on their response to the Covid-19 crisis in terms of innovation. The league table was compiled by StartupBlink, a Swiss-Israeli company that collates data on start-ups; the United Nations-backed Health Innovation Index; the Moscow Agency of Innovations; and partners such as tech database provider Crunchbase. While the Republic has punched above its…

Continue reading

Tiziana Life Sciences – Clinical pipeline update, resolutions seeking shareholder authority to issue new shares for cash & approval of proposed option grant – Posted in: Tiziana Life Sciences (TILS)

London, New York 21 April 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), the U.S. and U.K. biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has convened a general meeting (the “GM”) to consider proposals to take increased authorities to allot shares; consider the replacement of share option awards and to adopt…

Continue reading

Resilience, innovation and compassion – the independent retail response to Covid-19 – BetterRetailing.com April 10, 2020 – Posted in: Locosoco

Resilience, innovation and compassion – the independent retail response to Covid-19 By Nick Brown, Head of Sustainability at Coca-Cola European Partners Whilst we’re all living through unprecedented times, it has been warming to read about some of the positives that have started appearing in the national news over the past couple of weeks, pulling out the human stories that give us hope. The simple fact is that crises can bring out the best in people…

Continue reading